Countouriotis Athena
Insider CIK 1571469 · BMRN Director · AMBI Chief Medical Officer · HALO SVP and Chief Medical Officer · TROV Director · IOVA Director · ADVM SVP, Chief Medical Officer · TPTX President & CEO, Director · PASG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2026-06-16 | 2026-06-18 | 90,316 | — | $0 | 90,316 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-06-02 | 2026-06-04 | 7,490 | — | $0 | 21,040 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 10,539 | — | $0 | 10,539 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2025-06-13 | 2025-06-17 | 67,546 | — | $0 | 67,546 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 201,857 | — | $0 | 201,857 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-05-20 | 2025-05-22 | 6,650 | — | $0 | 13,550 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2024-06-11 | 2024-06-13 | 49,303 | — | $0 | 49,303 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 47,693 | — | $0 | 47,693 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-05-21 | 2024-05-23 | 4,720 | — | $0 | 6,900 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2024-03-01 | 2024-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-12-27 | 2023-12-28 | 2,180 | — | $0 | 2,180 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2023-06-06 | 2023-06-08 | 51,955 | — | $0 | 51,955 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2023-05-25 | 2023-05-26 | 24,000 | — | $0 | 24,000 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 155,844 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 989,971 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 173,389 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 325,000 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 67,575 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 224,640 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 101,775 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer | 2022-08-17 | 2022-08-17 | 110,959 | $76.00 | $8.43M | 0 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2022-06-10 | 2022-06-14 | 51,204 | — | $0 | 51,204 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 24,000 | — | $0 | 24,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2022-02-09 | 2022-02-11 | 224,640 | — | $0 | 224,640 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2022-02-09 | 2022-02-11 | 62,400 | — | $0 | 110,330 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2022-02-09 | 2022-02-11 | 2,971 | $36.30 | $107.8K | 47,930 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2021-06-29 | 2021-07-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2021-05-27 | 2021-05-28 | 16,918 | — | $0 | 16,918 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-02-11 | 2021-02-11 | 8,942 | — | $0 | 173,389 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-11 | 2021-02-11 | 3,052 | $138.55 | $422.9K | 50,195 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-11 | 2021-02-11 | 1,571 | $137.66 | $216.3K | 53,247 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-11 | 2021-02-11 | 4,319 | $136.45 | $589.3K | 54,818 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-02-11 | 2021-02-11 | 8,942 | $3.20 | $28.6K | 59,137 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-02-10 | 2021-02-11 | 25,392 | — | $0 | 182,331 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-10 | 2021-02-11 | 433 | $138.19 | $59.8K | 50,195 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-10 | 2021-02-11 | 2,081 | $137.46 | $286.1K | 50,628 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-10 | 2021-02-11 | 16,626 | $136.42 | $2.27M | 52,709 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-10 | 2021-02-11 | 5,227 | $135.72 | $709.4K | 69,335 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-10 | 2021-02-11 | 1,025 | $134.34 | $137.7K | 74,562 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-02-10 | 2021-02-11 | 25,392 | $3.20 | $81.3K | 75,587 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-02-09 | 2021-02-11 | 18,000 | — | $0 | 207,723 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-02-09 | 2021-02-11 | 7,666 | — | $0 | 67,575 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-09 | 2021-02-11 | 1,104 | $140.24 | $154.8K | 50,195 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-09 | 2021-02-11 | 13,290 | $139.69 | $1.86M | 51,299 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-09 | 2021-02-11 | 4,969 | $138.66 | $689.0K | 64,589 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-09 | 2021-02-11 | 103 | $137.58 | $14.2K | 69,558 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-09 | 2021-02-11 | 6,200 | $136.29 | $845.0K | 69,661 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-02-09 | 2021-02-11 | 7,666 | $3.20 | $24.5K | 75,861 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-02-09 | 2021-02-11 | 18,000 | $3.20 | $57.6K | 68,195 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2021-02-08 | 2021-02-10 | 101,775 | — | $0 | 101,775 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2021-02-08 | 2021-02-10 | 22,617 | — | $0 | 50,195 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2020-06-08 | 2020-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TPTX Turning Point Therapeutics | P Buy | 2020-05-21 | 2020-05-26 | 4,166 | $60.00 | $250.0K | 26,872 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-24 | 2020-03-25 | 10,000 | $14.98 | $149.8K | 18,900 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-03 | 8,900 | $18.00 | $160.2K | 8,900 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2020-02-27 | 2020-03-02 | 33,836 | — | $0 | 33,836 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-01-06 | 2020-01-08 | 325,000 | — | $0 | 325,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2019-12-10 | 2020-01-08 | 706 | $31.13 | $22.0K | 22,706 | SEC↗ |
| TPTX Turning Point Therapeutics | P Buy | 2019-09-10 | 2019-09-11 | 10,000 | $45.00 | $450.0K | 22,000 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 44,734 | — | $0 | 46,019 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2019-06-10 | 2019-06-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TPTX Turning Point Therapeutics | P Buy | 2019-04-22 | 2019-04-24 | 12,000 | $18.00 | $216.0K | 12,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2018-02-15 | 2018-02-20 | 160,000 | — | $0 | 160,000 | SEC↗ |
| TROV Trovagene, Inc. | A Award deriv | 2018-01-23 | 2018-01-25 | 54,322 | — | $0 | 92,428 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2017-06-19 | 2017-06-21 | 213,000 | — | $0 | 213,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2017-06-19 | 2017-06-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 45,568 | — | $0 | 45,568 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2017-02-22 | 2017-02-24 | 72,925 | — | $0 | 72,925 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2017-02-03 | 2017-02-06 | 18,496 | — | $0 | 55,487 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2017-02-03 | 2017-02-06 | 18,496 | — | $0 | 45,977 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2017-02-03 | 2017-02-06 | 6,900 | $12.26 | $84.6K | 39,077 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2017-01-05 | 2017-01-09 | 7,500 | — | $0 | 15,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2017-01-05 | 2017-01-09 | 7,500 | — | $0 | 27,481 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-06-30 | 2016-07-05 | 6,450 | — | $0 | 6,450 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2016-06-30 | 2016-07-05 | 6,450 | — | $0 | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2016-06-30 | 2016-07-05 | 6,450 | — | $0 | 20,088 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2016-06-30 | 2016-07-05 | 107 | $8.63 | $923 | 19,981 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-02-03 | 2016-02-04 | 125,523 | — | $0 | 125,523 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2016-02-03 | 2016-02-04 | 73,983 | — | $0 | 73,983 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2016-01-05 | 2016-01-07 | 7,500 | — | $0 | 22,500 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2016-01-05 | 2016-01-07 | 7,500 | — | $0 | 16,895 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2016-01-05 | 2016-01-07 | 3,257 | $16.39 | $53.4K | 13,638 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2015-12-31 | 2016-01-04 | 15,050 | — | $0 | 15,050 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | F Tax w/h | 2015-12-31 | 2016-01-04 | 5,655 | $17.33 | $98.0K | 9,395 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2015-01-05 | 2015-01-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2015-01-05 | 2015-01-06 | 250,000 | — | $0 | 250,000 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 18,882 | $15.00 | $283.2K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 100,645 | $9.00 | $905.8K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 76,481 | $3.19 | $244.0K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 45,000 | $4.20 | $189.0K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-05-15 | 2014-05-19 | 18,882 | — | $0 | 18,882 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-01-08 | 2014-01-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2013-07-16 | 2013-07-18 | 76,481 | — | $0 | 76,481 | SEC↗ |